ArticleInternational journal of computer assisted radiology and surgery2026
Design and development of an endoscopic robotic system and deep reinforcement learning path planning algorithm for fine-needle biopsy of liver lesions.
Article in International journal of computer assisted radiology and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper presents the design, development and evaluation of a novel robotic platform for endoscopic ultrasound-guided fine-needle biopsy of liver lesions. The system combines a four degrees-of-freedom (DoF) two-segment tendon-driven continuum robot (TDCR) endoscope with a two DoF superelastic nickel-titanium bevel-tip steerable needle. Needle path planning is achieved using NeedleNav, a soft actor-critic (SAC) deep reinforcement learning (DRL) model that generates collision-free trajectories to deep-seated lesions. This represents one of the first integrated systems combining a TDCR, steerable needle and DRL-based navigation, and the first application of a SAC to liver lesion targeting. Evaluation of the TDCR through tip tracking of circular, diamond-shaped and arc trajectories demonstrated a mean absolute error (MAE) of 13.19 mm. NeedleNav converged to obstacle avoidance trajectories in
Indexed as
Identifiers
42684647What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.